Showing results (61-70 of 123) with videos related to

Sort By:
Pageof 13
Annals of Internal Medicine|October 1, 1986
Is bone marrow examination in small-cell lung cancer really necessary?B Campling, I Quirt, G DeBoer, et al.
Cancer|April 1, 1984
VP-16 alone and in combination with cisplatin in previously treated patients with small cell lung cancerW K Evans, R Feld, D Osoba, et al.
Infection and Immunity|January 31, 2022
Microscopic Analysis of the Chlamydia abortus Inclusion and Its Interaction with Those Formed by Other Chlamydial SpeciesLotisha E Garvin, Addison G DeBoer, Steven J Carrell, et al.
Plastic and Reconstructive Surgery|August 1, 1987
Predictive value of staging investigations in patients with clinical stage I malignant melanomaN Iscoe, P Kersey, J Gapski, et al.
Cancer|October 15, 1980
Second primary respiratory tract malignancies in glottic carcinomaD J Wagenfeld, A R Harwood, D P Bryce, et al.
Hematology/Oncology Clinics of North America|April 1, 1994
Multidrug resistance. Clinical opportunities in diagnosis and circumventionH S Chan, G DeBoer, P S Thorner, et al.
BJU International|June 26, 2002
Urodynamic findings 3 months after radiotherapy in patients treated with conformal external beam radiotherapy for prostate carcinomaV Do, R Choo, G Deboer, et al.
Cancer Research|February 11, 1999
Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a prognostic factor independent of RasC Catzavelos, M S Tsao, G DeBoer, et al.
Archives of Internal Medicine|May 1, 1984
Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandoleR Feld, A Rachlis, P G Tuffnell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancerW K Evans, D Osoba, R Feld, et al.
Pageof 13